Vistin Pharma ASA (OSL:VISTN)

Norway flag Norway · Delayed Price · Currency is NOK
24.10
-0.40 (-1.63%)
At close: Jun 20, 2025
9.05%
Market Cap 1.12B
Revenue (ttm) 440.66M
Net Income (ttm) 76.79M
Shares Out 44.34M
EPS (ttm) 1.73
PE Ratio 14.61
Forward PE n/a
Dividend 1.25 (5.02%)
Ex-Dividend Date Jun 4, 2025
Volume 20,588
Average Volume 15,924
Open 24.20
Previous Close 24.50
Day's Range 24.00 - 24.50
52-Week Range 20.70 - 28.80
Beta 0.73
RSI 53.78
Earnings Date Aug 15, 2025

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway. [Read more]

Sector Healthcare
Founded 1969
Employees 75
Stock Exchange Oslo Børs
Ticker Symbol VISTN
Full Company Profile

Financial Performance

In 2024, Vistin Pharma ASA's revenue was 429.50 million, a decrease of -2.01% compared to the previous year's 438.33 million. Earnings were 62.75 million, an increase of 37.62%.

Financial Statements

News

There is no news available yet.